Immunovant (IMVT) Stock Price Today, Chart, Quote and News | baraka

I

Immunovant (IMVT)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Immunovant (IMVT)

Immunovant, Inc., formerly Health Sciences Acquisitions Corp, is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for patients with autoimmune diseases. It is developing IMVT-1401, a human anti-FcRn monoclon... Read more

Open
USD29.37
High
USD29.76
Low
USD28.83
52 Week High
USD45.58
Monthly Return
-7.40%
Revenue
--

Daily Vol.
701.48k
Avg. Daily Vol.
1.10M
Market Cap.
3.9B
52 Week Low
17.53
Annual Return
49.90%

Stock News

Encompass Health First Quarter 2024 Earnings: Beats Expectations

Encompass Health First Quarter 2024 Earnings: Beats Expectations

Yahoo

Calculating The Intrinsic Value Of TopBuild Corp. (NYSE:BLD)

Calculating The Intrinsic Value Of TopBuild Corp. (NYSE:BLD)

Yahoo

Spok Holdings (NASDAQ:SPOK) Is Due To Pay A Dividend Of $0.3125

Spok Holdings (NASDAQ:SPOK) Is Due To Pay A Dividend Of $0.3125

Yahoo

Turning Point Brands (NYSE:TPB) Has Announced A Dividend Of $0.07

Turning Point Brands (NYSE:TPB) Has Announced A Dividend Of $0.07

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.